1. Home
  2. SLQT vs PCRX Comparison

SLQT vs PCRX Comparison

Compare SLQT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SelectQuote Inc.

SLQT

SelectQuote Inc.

HOLD

Current Price

$0.51

Market Cap

132.7M

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.42

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLQT
PCRX
Founded
1999
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.7M
1.1B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
SLQT
PCRX
Price
$0.51
$25.42
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$2.88
$30.25
AVG Volume (30 Days)
1.3M
416.5K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.19
Revenue
$1,618,499,000.00
$541,533,000.00
Revenue This Year
$10.97
$6.78
Revenue Next Year
$6.14
$8.54
P/E Ratio
N/A
$136.21
Revenue Growth
6.02
26.04
52 Week Low
$0.48
$18.80
52 Week High
$2.22
$27.66

Technical Indicators

Market Signals
Indicator
SLQT
PCRX
Relative Strength Index (RSI) 35.24 48.87
Support Level $0.48 $24.61
Resistance Level $0.79 $26.93
Average True Range (ATR) 0.05 0.66
MACD -0.01 0.04
Stochastic Oscillator 9.69 52.92

Price Performance

Historical Comparison
SLQT
PCRX

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: